Search

everythinglearnresearchcommunity

for

Search:↓

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Understanding different species' regeneration can improve mammalian healing.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Polyesters show promise for repairing damaged blood vessels.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

X-ray microbeams can mimic cosmic rays' effects on tissue, aiding wound healing and hair growth.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

There is no link between hair loss and prostate enlargement.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

A detailed 3D model of human skin was created to help develop artificial skin.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Mice with human skin protein K8 had more skin problems and cancer.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.